Lenalidomide Price Case Progress

Access to Medicine: Lenalidomide

Cancer Alliance submitted a case for the investigation of excessive pricing for lenalidomide to the South African Competition Commission in January 2023. The CompCom confirmed their intention to investigate this case in February 2023.

• Appendix A, 2024-02-06, Tbls 1-10.pdf
• Appendix A, 2024-02-06, Tbls 13 – 14.pdf
• Appendix B, Du Toit Statement.pdf
• Appendix C, 2024-02-06, incl tables.pdf
• Memorandum in Support of a Referral, 2024-02-06.pdf